BioLight Israeli Life Sciences Investments Ltd

About:

BioLight Life Sciences Investments Ltd. invests in, manages and commercializes biomedical innovations grouped into “clusters” around

Website: http://www.bio-light.co.il

Top Investors: Cybele Holdings

Description:

BioLight Life Sciences Ltd. is a leading company investing in companies and managing projects relating to eye disease and their treatment. BioLight’s portfolio companies engage in advanced medical devices, medication, diagnostics and digital medicine and all exemplify the enormous potential of Israeli innovation in these fields. Development and commercialization of the company’s ophthalmic technologies and products. The ophthalmic products developed by the companies in the BioLight group are aimed at innovative diagnosis and treatments for the needs of patient groups suffering from eye diseases. The different ophthalmic products are in various commercialization and clinical (or pre-clinical) phases. BioLight intends, in line with its financial capabilities, to continue supplementing and expanding the array of technologies and products under development, whether through investment in additional companies or through business development and expansion of the activity of the existing companies.

Total Funding Amount:

$16.5M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Tel Aviv, Tel Aviv, Israel

Founded Date:

2005-01-01

Contact Email:

biolight(AT)bio-light.co.il

Founders:

Israel Makov

Number of Employees:

1-10

Last Funding Date:

2018-05-01

IPO Status:

Public

Industries:

© 2025 bioDAO.ai